RK STRATEGIES, INC.

Lobbying for CLEARMIND MEDICINE, INC · Developer of Psychedelics Medicines

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$10,000.00

What the client paid this registrant for the period.

Client based in

British Columbia

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 4

Health Issues

Psychedelic Legislation

Defense

Psychedelics legislation National Defense Authorization Act, 2026

Alcohol and Drug Abuse

Psychedelic Legislation

Veterans

Psychedelic legislation

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.